{
    "name": "phenazopyridine",
    "comment": "Rx, OTC",
    "other_names": [
        "Azo Standard",
        "Pyridium",
        "Prodium",
        "Pyridiate",
        "Baridium",
        "Uricalm",
        "Urodine",
        "UTI Relief"
    ],
    "classes": [
        "Analgesics",
        "Urinary"
    ],
    "source": "https://reference.medscape.com/drug/azo-standard-pyridium-phenazopyridine-343349",
    "pregnancy": {
        "common": [
            "Pregnancy category: B",
            "Lactation: Not known if excreted in breast milk; exercise caution"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: Not known if excreted in breast milk; exercise caution"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity",
                "Renal impairment (CrCl <50mL/min)"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Changes urine color; may affect UA based on spectrometry or color reactions",
                "May stain contact lenses",
                "Discontinue if yellowish color of skin or sclera, as this is an indication of drug accumulation due to renal failure; monitor geriatric patients due to greater risk",
                "Self-medication should not continue >2 days; if pain persists, consult physician",
                "Intended as analgesic, not for treatment of UTI",
                "Use caution in patients with G6PD deficiency; hemolytic anemia may occur in the setting of chronic overdose",
                "Not for treatment of urinary inferction; acts only as analgesic",
                "Discontinue over the counter use if symptoms last more than 2 days or adverse effects occur",
                "May stain fiber or clothing"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "prilocaine",
            "description": {
                "common": "phenazopyridine increases toxicity of prilocaine by Other (see comment). Modify Therapy/Monitor Closely. \nComment: Phenazopyridine may significantly increase risk of methemoglobinemia when coadministered with prilocaine. Monitor patients closely."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Headache",
            "percent": null
        },
        {
            "name": "Vertigo",
            "percent": null
        },
        {
            "name": "Rash",
            "percent": null
        },
        {
            "name": "Pruritus",
            "percent": null
        },
        {
            "name": "Mild GI disturbances",
            "percent": null
        },
        {
            "name": "Methemoglobinemia",
            "percent": null
        },
        {
            "name": "Hemolytic anemia",
            "percent": null
        },
        {
            "name": "Skin pigmentation",
            "percent": null
        },
        {
            "name": "Transient ARF",
            "percent": null
        },
        {
            "name": "Renal calculi",
            "percent": null
        },
        {
            "name": "Staining of contact lenses",
            "percent": null
        },
        {
            "name": "Hepatic",
            "percent": null
        },
        {
            "name": "renal toxicity",
            "percent": null
        }
    ]
}